Eye Care in Germany

Euromonitor International, July 2012, Pages: 30

Retail value sales of OTC eye care products are set to grow by between 3-4% in Germany in 2011 to reach €139 million overall. Factors in favour of the category’s development are increasingly long working hours, dry air in living spaces caused by air conditioning and heating as well as polluted air, especially in cities. All these lead to an increased incidence of red eye and dry eye among German consumers; conditions that are increasingly treated with OTC eye care products.

Euromonitor International's Eye Care in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Allergy Eye Care, Standard Eye Care.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Eye Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

EYE CARE IN GERMANY
Euromonitor International
July 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Eye Care by Category: Value 2006-2011
Table 2 Sales of Eye Care by Category: % Value Growth 2006-2011
Table 3 Standard Eye Care by Format: % Value Breakdown 2007-2011
Table 4 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
Table 5 Eye Care Company Shares by Value 2007-2011
Table 6 Eye Care Brand Shares by Value 2008-2011
Table 7 Forecast Sales of Eye Care by Category: Value 2011-2016
Table 8 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016
Johnson & Johnson GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 1 Johnson & Johnson GmbH: Key Facts
Summary 2 Johnson & Johnson GmbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Johnson & Johnson GmbH: Competitive Position 2011
Mann Chem-pharm Fabrik Gmbh, Dr Gerhard in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 4 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Key Facts
Summary 5 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Competitive Position 2011
Ratiopharm GmbH & Co in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 7 Ratiopharm GmbH & Co: Key Facts
Summary 8 Ratiopharm GmbH & Co: Operational Indicators
Company Background
Production
Summary 9 Ratiopharm GmbH & Co: Production Statistics 2011
Competitive Positioning
Summary 10 Ratiopharm GmbH & Co: Competitive Position 2011
Executive Summary
Consumer Health Overall Stagnating in Germany in 2011
Market Under Pressure From Healthier Diets and More Exercise
Very Fragmented Market Continues To Be Led by Bayer Vital
Consumer Healthcare Most Often Sold in Health and Beauty Retailers
Small Decline of Consumer Health Expected Over Forecast Period in Germany
Key Trends and Developments
Ongoing Relatively Favourable Economic Conditions in Germany in 2011
Demographic Changes Continue To Influence Consumer Health in Germany
Increasing Shares of Sales Through Internet Retailing in Consumer Health
Consumer Lifestyle Issues Offer Opportunities for Manufacturers and Retailers
Innovation Essential for Premium Brands To Thrive in Consumer Health
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 10 Life Expectancy at Birth 2006-2011
Market Data
Table 11 Sales of Consumer Health by Category: Value 2006-2011
Table 12 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 13 Consumer Health Company Shares 2007-2011
Table 14 Consumer Health Brand Shares 2008-2011
Table 15 Penetration of Private Label by Category 2006-2011
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 18 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Switches
Summary 11 OTC - Switches 2010-2011
Definitions
Sources
Summary 12 Research Sources

A good year in 2005
The German OTC health market registered healthy growth in 2005, with value sales rising at a rate significantly above the CAGR for the review period. This positive development was underpinned by increased health consciousness, the effects of the ubiquitous wellness trend and – particularly – the ongoing effects of the health reforms, which came into effect in June 2004.

All sectors experienced growth with the exception of digestive remedies, with the strongest sales growth registered by preventive healthcare products and OTC products related to stress-relief, such as vitamins and dietary supplements, NRT smoking cessation aids, eye care and calming and sleeping products.

Pharmacies remain the most important distribution channel for OTC healthcare products, despite timid moves towards the liberalisation of distribution. Generics and private label products are important in certain areas and have benefited from ongoing difficult economic conditions, characterised by low consumer confidence and consequent sensitivity to prices.

Companies Mentioned Include:
- McNeil GmbH & Co oHG
- Pfizer Pharma GmbH
- Novartis Consumer Health GmbH
- Boots Healthcare Deutschland
- Bayer Vital GmbH
- Novartis Consumer Health GmbH
- Boehringer Ingelheim Pharma GmbH & Co KG
- Beiersdorf AG
- Ratiopharm GmbH & Co
- Abtei Pharma Vertriebs- GmbH
- Procter & Gamble GmbH
- STADA Arzneimittel AG
- Whitehall Much GmbH
- MCM Klosterfrau Vertriebgesellschaft mbH
- Mann Chem-Pharm Fabrik GmbH, Dr Gerhard
- Madaus AG
- Impuls-Vermarktung GmbH & Co KG
- Spitzner Arzneimittel GmbH
- Roche Consumer Health Deutschland GmbH
- Ricola AG
- Hexal AG
- Pfizer Consumer Healthcare GmbH
- Aventis Pharma Deutschland GmbH (Nattermann & Cie GmbH)
- Nattermann & Cie GmbH
- Johnson & Johnson GmbH
- Lichtwer Pharma AG
- Pohl-Boskamp GmbH und Co
- Weleda AG
- Engelhard Arzneimittel GmbH and Co KG
- Bad Heilbrunner Naturheilmittel GmbH & Co
- Gödecke AG
- Solvay Arzneimittel GmbH
- Viatris GmbH & Co KG (formerly known as Asta Medica AG)
- Merck KGaA
- Woelm Pharma GmbH & Co
- Dr Rentschler
- Arzneimittel GmbH & Co
- GlaxoSmithKline GmbH & Co KG
- Wolff GmbH & Co Arzneimittel, Dr August

Customers who bought this item also bought

• Fragrances in Germany
• Surface Care in Germany
• Medicated Skin Care in Germany
• Toilet Care in Germany
• Adult Mouth Care in Germany
• Colour Cosmetics in Germany
• Air Care in Germany
• Consumer Trends in the Skincare Market in Germany
• Beauty and Personal Care Packaging in Germany
• Dishwashing in Germany